NZD 0.03
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 7.73 Million NZD | -63.06% |
2023 | 20.95 Million NZD | -37.6% |
2022 | 33.57 Million NZD | 1.28% |
2021 | 33.14 Million NZD | 110.77% |
2020 | 15.72 Million NZD | 41.26% |
2019 | 11.13 Million NZD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 7.73 Million NZD | -63.06% |
2024 Q1 | 10.03 Million NZD | -52.12% |
2024 Q4 | 7.73 Million NZD | 0.0% |
2024 Q2 | 10.03 Million NZD | 0.0% |
2023 Q3 | 20.95 Million NZD | -27.97% |
2023 Q1 | 29.08 Million NZD | -13.36% |
2023 Q4 | 20.95 Million NZD | 0.0% |
2023 FY | 20.95 Million NZD | -37.6% |
2023 Q2 | 29.08 Million NZD | 0.0% |
2022 Q1 | 28.01 Million NZD | -15.47% |
2022 FY | 33.57 Million NZD | 1.28% |
2022 Q4 | 33.57 Million NZD | 0.0% |
2022 Q3 | 33.57 Million NZD | 19.82% |
2022 Q2 | 28.01 Million NZD | 0.0% |
2021 Q1 | 32.12 Million NZD | 103.85% |
2021 Q3 | 30.85 Million NZD | -3.97% |
2021 Q4 | 33.14 Million NZD | 7.45% |
2021 Q2 | 32.12 Million NZD | 0.0% |
2021 FY | 33.14 Million NZD | 110.77% |
2020 FY | 15.72 Million NZD | 41.26% |
2020 Q4 | 15.76 Million NZD | 0.22% |
2020 Q3 | 15.72 Million NZD | 0.0% |
2020 Q1 | - NZD | 0.0% |
2019 FY | 11.13 Million NZD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AFT Pharmaceuticals Limited | 165.25 Million NZD | 95.317% |
Greenfern Industries Limited | 3.21 Million NZD | -140.708% |